Business Context and Reporting Period
Company: Wearable Devices Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Month of April 2025 (Report No. 3)
Date of Filing: April 30, 2025
Principal Executive Offices: Yokne-am Illit, Israel
The filing discloses a warrant inducement transaction entered into on April 29, 2025, designed to raise capital through the exercise of existing warrants by a specific holder in exchange for the issuance of new warrants.
Key Financial Metrics and Transaction Details
- Gross Proceeds: Approximately $1.2 million expected from the exercise of existing warrants.
- Transaction Structure:
- Existing Warrants Exercised: 830,500 warrants (205,500 from Nov 2024 issuance; 625,000 from Jan 2025 issuance).
- Exercise Price (Existing): Reduced from $4.00 to $1.45 per share for this transaction.
- New Warrants Issued: 1,661,000 warrants (2x the number of shares purchased).
- Exercise Price (New): $1.45 per share.
- Transaction Costs:
- Financial Advisor Fee: 8.0% of aggregate gross proceeds (paid to A.G.P./Alliance Global Partners).
- Legal Fees: Up to $25,000 payable to the Financial Advisor.
- Use of Proceeds: Working capital and general corporate purposes.
Note: The filing does not provide specific revenue, profit, cash flow, margin, or debt figures for the period. It focuses exclusively on the capital raise transaction.
Material Changes and Transaction Mechanics
The primary material change is the reduction of the exercise price for a specific holder's existing warrants from $4.00 to $1.45 per share, contingent upon the issuance of new warrants. This inducement allows the holder to purchase 830,500 shares at the lower price while receiving 1,661,000 new warrants.
Key Terms of New Warrants:
- Duration: Immediately exercisable; expires five years from issuance.
- Beneficial Ownership Limitations: Holders cannot exercise to own more than 4.99% (or 9.99% at election) of outstanding shares, with a hard cap of 24.99% beneficial ownership.
- Cashless Exercise: Available after six months if a registration statement for resale is not effective.
- Liquidity: No established trading market is expected for the new warrants.
Outlook, Risks, and Contingencies
Management Commentary and Outlook: The Company expects the transaction to close on or about April 30, 2025, subject to customary conditions. The Company has committed to filing a registration statement for the resale of New Warrant Shares within 30 days and keeping it effective until all shares are sold.
Risks and Contingencies:
- Forward-Looking Statements: Actual results may differ materially due to uncertainties in the cybersecurity and telecom markets, product acceptance, and competition.
- Trading Restrictions: The New Warrants and underlying shares are sold under Section 4(a)(2) exemption and cannot be resold in the U.S. without registration or an applicable exemption.
- Variable Rate Transaction Lock-up: The Company agreed not to effect any Variable Rate Transaction for 30 days post-closing.
- Fundamental Transactions: In the event of a merger or similar event, holders may receive cash equal to the Black Scholes Value of unexercised warrants.
Investor Verification Checklist
- Verify the actual closing date and confirmation of the $1.2 million gross proceeds receipt.
- Confirm the filing and effectiveness of the Form F-1 or F-3 registration statement for the resale of New Warrant Shares.
- Review the impact of the 8.0% placement fee and legal costs on the net cash inflow.
- Assess the dilution impact of issuing 1,661,000 new warrants alongside the 830,500 shares from the exercise.
- Check for any subsequent filings regarding the trading market status of the new warrants.